 | • レポートコード：MRC308GR11427 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のシュウ酸エスシタロプラムAPIの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のシュウ酸エスシタロプラムAPI市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– シュウ酸エスシタロプラムAPIの成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
シュウ酸エスシタロプラムAPI市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・USDMF及びCOS/E-DM、USDMFまたはCOS/E-DMのみ
用途別セグメント
・うつ病薬、不安薬
主要な市場プレーヤー
・Sichuan Kelun、Zhejiang Huahai、Haisen Pharma、Viatris、Cipla、Aurobindo、Hetero Labs、Neuland、Smilax Laboratories、Jubilant Generics、Cadila Pharmaceuticals、Natco Pharma、Shodhana Laboratories、Dr. Reddy’s
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、シュウ酸エスシタロプラムAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なシュウ酸エスシタロプラムAPIメーカーの企業概要、2019年～2022年までのシュウ酸エスシタロプラムAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なシュウ酸エスシタロプラムAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別シュウ酸エスシタロプラムAPIの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのシュウ酸エスシタロプラムAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのシュウ酸エスシタロプラムAPI市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびシュウ酸エスシタロプラムAPIの産業チェーンを掲載しています。
・第14、15章では、シュウ酸エスシタロプラムAPIの販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– シュウ酸エスシタロプラムAPIの概要
– 種類別分析（2018年vs2022年vs2029年）：USDMF及びCOS/E-DM、USDMFまたはCOS/E-DMのみ
– 用途別分析（2018年vs2022年vs2029年）：うつ病薬、不安薬
– 世界のシュウ酸エスシタロプラムAPI市場規模・予測
– 世界のシュウ酸エスシタロプラムAPI生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sichuan Kelun、Zhejiang Huahai、Haisen Pharma、Viatris、Cipla、Aurobindo、Hetero Labs、Neuland、Smilax Laboratories、Jubilant Generics、Cadila Pharmaceuticals、Natco Pharma、Shodhana Laboratories、Dr. Reddy’s
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：USDMF及びCOS/E-DM、USDMFまたはCOS/E-DMのみ
・用途別分析2018年-2029年：うつ病薬、不安薬
・シュウ酸エスシタロプラムAPIの北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・シュウ酸エスシタロプラムAPIのヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・シュウ酸エスシタロプラムAPIのアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・シュウ酸エスシタロプラムAPIの南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・シュウ酸エスシタロプラムAPIの中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Escitalopram Oxalate API
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Escitalopram Oxalate API Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Both USDMF and COS/E-DM
1.3.3 Only USDMF or COS/E-DM
1.4 Market Analysis by Application
1.4.1 Overview: Global Escitalopram Oxalate API Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Depression Drug
1.4.3 Anxiety Drug
1.5 Global Escitalopram Oxalate API Market Size & Forecast
1.5.1 Global Escitalopram Oxalate API Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Escitalopram Oxalate API Sales Quantity (2018-2029)
1.5.3 Global Escitalopram Oxalate API Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Sichuan Kelun
2.1.1 Sichuan Kelun Details
2.1.2 Sichuan Kelun Major Business
2.1.3 Sichuan Kelun Escitalopram Oxalate API Product and Services
2.1.4 Sichuan Kelun Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Sichuan Kelun Recent Developments/Updates
2.2 Zhejiang Huahai
2.2.1 Zhejiang Huahai Details
2.2.2 Zhejiang Huahai Major Business
2.2.3 Zhejiang Huahai Escitalopram Oxalate API Product and Services
2.2.4 Zhejiang Huahai Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Zhejiang Huahai Recent Developments/Updates
2.3 Haisen Pharma
2.3.1 Haisen Pharma Details
2.3.2 Haisen Pharma Major Business
2.3.3 Haisen Pharma Escitalopram Oxalate API Product and Services
2.3.4 Haisen Pharma Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Haisen Pharma Recent Developments/Updates
2.4 Viatris
2.4.1 Viatris Details
2.4.2 Viatris Major Business
2.4.3 Viatris Escitalopram Oxalate API Product and Services
2.4.4 Viatris Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Viatris Recent Developments/Updates
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Escitalopram Oxalate API Product and Services
2.5.4 Cipla Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Cipla Recent Developments/Updates
2.6 Aurobindo
2.6.1 Aurobindo Details
2.6.2 Aurobindo Major Business
2.6.3 Aurobindo Escitalopram Oxalate API Product and Services
2.6.4 Aurobindo Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Aurobindo Recent Developments/Updates
2.7 Hetero Labs
2.7.1 Hetero Labs Details
2.7.2 Hetero Labs Major Business
2.7.3 Hetero Labs Escitalopram Oxalate API Product and Services
2.7.4 Hetero Labs Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Hetero Labs Recent Developments/Updates
2.8 Neuland
2.8.1 Neuland Details
2.8.2 Neuland Major Business
2.8.3 Neuland Escitalopram Oxalate API Product and Services
2.8.4 Neuland Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Neuland Recent Developments/Updates
2.9 Smilax Laboratories
2.9.1 Smilax Laboratories Details
2.9.2 Smilax Laboratories Major Business
2.9.3 Smilax Laboratories Escitalopram Oxalate API Product and Services
2.9.4 Smilax Laboratories Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Smilax Laboratories Recent Developments/Updates
2.10 Jubilant Generics
2.10.1 Jubilant Generics Details
2.10.2 Jubilant Generics Major Business
2.10.3 Jubilant Generics Escitalopram Oxalate API Product and Services
2.10.4 Jubilant Generics Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Jubilant Generics Recent Developments/Updates
2.11 Cadila Pharmaceuticals
2.11.1 Cadila Pharmaceuticals Details
2.11.2 Cadila Pharmaceuticals Major Business
2.11.3 Cadila Pharmaceuticals Escitalopram Oxalate API Product and Services
2.11.4 Cadila Pharmaceuticals Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Cadila Pharmaceuticals Recent Developments/Updates
2.12 Natco Pharma
2.12.1 Natco Pharma Details
2.12.2 Natco Pharma Major Business
2.12.3 Natco Pharma Escitalopram Oxalate API Product and Services
2.12.4 Natco Pharma Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Natco Pharma Recent Developments/Updates
2.13 Shodhana Laboratories
2.13.1 Shodhana Laboratories Details
2.13.2 Shodhana Laboratories Major Business
2.13.3 Shodhana Laboratories Escitalopram Oxalate API Product and Services
2.13.4 Shodhana Laboratories Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Shodhana Laboratories Recent Developments/Updates
2.14 Dr. Reddy’s
2.14.1 Dr. Reddy’s Details
2.14.2 Dr. Reddy’s Major Business
2.14.3 Dr. Reddy’s Escitalopram Oxalate API Product and Services
2.14.4 Dr. Reddy’s Escitalopram Oxalate API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Dr. Reddy’s Recent Developments/Updates
3 Competitive Environment: Escitalopram Oxalate API by Manufacturer
3.1 Global Escitalopram Oxalate API Sales Quantity by Manufacturer (2018-2023)
3.2 Global Escitalopram Oxalate API Revenue by Manufacturer (2018-2023)
3.3 Global Escitalopram Oxalate API Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Escitalopram Oxalate API by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Escitalopram Oxalate API Manufacturer Market Share in 2022
3.4.2 Top 6 Escitalopram Oxalate API Manufacturer Market Share in 2022
3.5 Escitalopram Oxalate API Market: Overall Company Footprint Analysis
3.5.1 Escitalopram Oxalate API Market: Region Footprint
3.5.2 Escitalopram Oxalate API Market: Company Product Type Footprint
3.5.3 Escitalopram Oxalate API Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Escitalopram Oxalate API Market Size by Region
4.1.1 Global Escitalopram Oxalate API Sales Quantity by Region (2018-2029)
4.1.2 Global Escitalopram Oxalate API Consumption Value by Region (2018-2029)
4.1.3 Global Escitalopram Oxalate API Average Price by Region (2018-2029)
4.2 North America Escitalopram Oxalate API Consumption Value (2018-2029)
4.3 Europe Escitalopram Oxalate API Consumption Value (2018-2029)
4.4 Asia-Pacific Escitalopram Oxalate API Consumption Value (2018-2029)
4.5 South America Escitalopram Oxalate API Consumption Value (2018-2029)
4.6 Middle East and Africa Escitalopram Oxalate API Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
5.2 Global Escitalopram Oxalate API Consumption Value by Type (2018-2029)
5.3 Global Escitalopram Oxalate API Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
6.2 Global Escitalopram Oxalate API Consumption Value by Application (2018-2029)
6.3 Global Escitalopram Oxalate API Average Price by Application (2018-2029)
7 North America
7.1 North America Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
7.2 North America Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
7.3 North America Escitalopram Oxalate API Market Size by Country
7.3.1 North America Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
7.3.2 North America Escitalopram Oxalate API Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
8.2 Europe Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
8.3 Europe Escitalopram Oxalate API Market Size by Country
8.3.1 Europe Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
8.3.2 Europe Escitalopram Oxalate API Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Escitalopram Oxalate API Market Size by Region
9.3.1 Asia-Pacific Escitalopram Oxalate API Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Escitalopram Oxalate API Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
10.2 South America Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
10.3 South America Escitalopram Oxalate API Market Size by Country
10.3.1 South America Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
10.3.2 South America Escitalopram Oxalate API Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Escitalopram Oxalate API Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Escitalopram Oxalate API Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Escitalopram Oxalate API Market Size by Country
11.3.1 Middle East & Africa Escitalopram Oxalate API Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Escitalopram Oxalate API Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Escitalopram Oxalate API Market Drivers
12.2 Escitalopram Oxalate API Market Restraints
12.3 Escitalopram Oxalate API Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Escitalopram Oxalate API and Key Manufacturers
13.2 Manufacturing Costs Percentage of Escitalopram Oxalate API
13.3 Escitalopram Oxalate API Production Process
13.4 Escitalopram Oxalate API Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Escitalopram Oxalate API Typical Distributors
14.3 Escitalopram Oxalate API Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Escitalopram Oxalate API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Escitalopram Oxalate API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Sichuan Kelun Basic Information, Manufacturing Base and Competitors
Table 4. Sichuan Kelun Major Business
Table 5. Sichuan Kelun Escitalopram Oxalate API Product and Services
Table 6. Sichuan Kelun Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Sichuan Kelun Recent Developments/Updates
Table 8. Zhejiang Huahai Basic Information, Manufacturing Base and Competitors
Table 9. Zhejiang Huahai Major Business
Table 10. Zhejiang Huahai Escitalopram Oxalate API Product and Services
Table 11. Zhejiang Huahai Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Zhejiang Huahai Recent Developments/Updates
Table 13. Haisen Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Haisen Pharma Major Business
Table 15. Haisen Pharma Escitalopram Oxalate API Product and Services
Table 16. Haisen Pharma Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Haisen Pharma Recent Developments/Updates
Table 18. Viatris Basic Information, Manufacturing Base and Competitors
Table 19. Viatris Major Business
Table 20. Viatris Escitalopram Oxalate API Product and Services
Table 21. Viatris Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Viatris Recent Developments/Updates
Table 23. Cipla Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Major Business
Table 25. Cipla Escitalopram Oxalate API Product and Services
Table 26. Cipla Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Cipla Recent Developments/Updates
Table 28. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 29. Aurobindo Major Business
Table 30. Aurobindo Escitalopram Oxalate API Product and Services
Table 31. Aurobindo Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Aurobindo Recent Developments/Updates
Table 33. Hetero Labs Basic Information, Manufacturing Base and Competitors
Table 34. Hetero Labs Major Business
Table 35. Hetero Labs Escitalopram Oxalate API Product and Services
Table 36. Hetero Labs Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Hetero Labs Recent Developments/Updates
Table 38. Neuland Basic Information, Manufacturing Base and Competitors
Table 39. Neuland Major Business
Table 40. Neuland Escitalopram Oxalate API Product and Services
Table 41. Neuland Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Neuland Recent Developments/Updates
Table 43. Smilax Laboratories Basic Information, Manufacturing Base and Competitors
Table 44. Smilax Laboratories Major Business
Table 45. Smilax Laboratories Escitalopram Oxalate API Product and Services
Table 46. Smilax Laboratories Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Smilax Laboratories Recent Developments/Updates
Table 48. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 49. Jubilant Generics Major Business
Table 50. Jubilant Generics Escitalopram Oxalate API Product and Services
Table 51. Jubilant Generics Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Jubilant Generics Recent Developments/Updates
Table 53. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Cadila Pharmaceuticals Major Business
Table 55. Cadila Pharmaceuticals Escitalopram Oxalate API Product and Services
Table 56. Cadila Pharmaceuticals Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Cadila Pharmaceuticals Recent Developments/Updates
Table 58. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 59. Natco Pharma Major Business
Table 60. Natco Pharma Escitalopram Oxalate API Product and Services
Table 61. Natco Pharma Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Natco Pharma Recent Developments/Updates
Table 63. Shodhana Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Shodhana Laboratories Major Business
Table 65. Shodhana Laboratories Escitalopram Oxalate API Product and Services
Table 66. Shodhana Laboratories Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Shodhana Laboratories Recent Developments/Updates
Table 68. Dr. Reddy's Basic Information, Manufacturing Base and Competitors
Table 69. Dr. Reddy's Major Business
Table 70. Dr. Reddy's Escitalopram Oxalate API Product and Services
Table 71. Dr. Reddy's Escitalopram Oxalate API Sales Quantity (MT), Average Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Dr. Reddy's Recent Developments/Updates
Table 73. Global Escitalopram Oxalate API Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 74. Global Escitalopram Oxalate API Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Escitalopram Oxalate API Average Price by Manufacturer (2018-2023) & (US$/Kg)
Table 76. Market Position of Manufacturers in Escitalopram Oxalate API, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Escitalopram Oxalate API Production Site of Key Manufacturer
Table 78. Escitalopram Oxalate API Market: Company Product Type Footprint
Table 79. Escitalopram Oxalate API Market: Company Product Application Footprint
Table 80. Escitalopram Oxalate API New Market Entrants and Barriers to Market Entry
Table 81. Escitalopram Oxalate API Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Escitalopram Oxalate API Sales Quantity by Region (2018-2023) & (MT)
Table 83. Global Escitalopram Oxalate API Sales Quantity by Region (2024-2029) & (MT)
Table 84. Global Escitalopram Oxalate API Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Escitalopram Oxalate API Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Escitalopram Oxalate API Average Price by Region (2018-2023) & (US$/Kg)
Table 87. Global Escitalopram Oxalate API Average Price by Region (2024-2029) & (US$/Kg)
Table 88. Global Escitalopram Oxalate API Sales Quantity by Type (2018-2023) & (MT)
Table 89. Global Escitalopram Oxalate API Sales Quantity by Type (2024-2029) & (MT)
Table 90. Global Escitalopram Oxalate API Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Escitalopram Oxalate API Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Escitalopram Oxalate API Average Price by Type (2018-2023) & (US$/Kg)
Table 93. Global Escitalopram Oxalate API Average Price by Type (2024-2029) & (US$/Kg)
Table 94. Global Escitalopram Oxalate API Sales Quantity by Application (2018-2023) & (MT)
Table 95. Global Escitalopram Oxalate API Sales Quantity by Application (2024-2029) & (MT)
Table 96. Global Escitalopram Oxalate API Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Escitalopram Oxalate API Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Escitalopram Oxalate API Average Price by Application (2018-2023) & (US$/Kg)
Table 99. Global Escitalopram Oxalate API Average Price by Application (2024-2029) & (US$/Kg)
Table 100. North America Escitalopram Oxalate API Sales Quantity by Type (2018-2023) & (MT)
Table 101. North America Escitalopram Oxalate API Sales Quantity by Type (2024-2029) & (MT)
Table 102. North America Escitalopram Oxalate API Sales Quantity by Application (2018-2023) & (MT)
Table 103. North America Escitalopram Oxalate API Sales Quantity by Application (2024-2029) & (MT)
Table 104. North America Escitalopram Oxalate API Sales Quantity by Country (2018-2023) & (MT)
Table 105. North America Escitalopram Oxalate API Sales Quantity by Country (2024-2029) & (MT)
Table 106. North America Escitalopram Oxalate API Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Escitalopram Oxalate API Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Escitalopram Oxalate API Sales Quantity by Type (2018-2023) & (MT)
Table 109. Europe Escitalopram Oxalate API Sales Quantity by Type (2024-2029) & (MT)
Table 110. Europe Escitalopram Oxalate API Sales Quantity by Application (2018-2023) & (MT)
Table 111. Europe Escitalopram Oxalate API Sales Quantity by Application (2024-2029) & (MT)
Table 112. Europe Escitalopram Oxalate API Sales Quantity by Country (2018-2023) & (MT)
Table 113. Europe Escitalopram Oxalate API Sales Quantity by Country (2024-2029) & (MT)
Table 114. Europe Escitalopram Oxalate API Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Escitalopram Oxalate API Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Escitalopram Oxalate API Sales Quantity by Type (2018-2023) & (MT)
Table 117. Asia-Pacific Escitalopram Oxalate API Sales Quantity by Type (2024-2029) & (MT)
Table 118. Asia-Pacific Escitalopram Oxalate API Sales Quantity by Application (2018-2023) & (MT)
Table 119. Asia-Pacific Escitalopram Oxalate API Sales Quantity by Application (2024-2029) & (MT)
Table 120. Asia-Pacific Escitalopram Oxalate API Sales Quantity by Region (2018-2023) & (MT)
Table 121. Asia-Pacific Escitalopram Oxalate API Sales Quantity by Region (2024-2029) & (MT)
Table 122. Asia-Pacific Escitalopram Oxalate API Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Escitalopram Oxalate API Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Escitalopram Oxalate API Sales Quantity by Type (2018-2023) & (MT)
Table 125. South America Escitalopram Oxalate API Sales Quantity by Type (2024-2029) & (MT)
Table 126. South America Escitalopram Oxalate API Sales Quantity by Application (2018-2023) & (MT)
Table 127. South America Escitalopram Oxalate API Sales Quantity by Application (2024-2029) & (MT)
Table 128. South America Escitalopram Oxalate API Sales Quantity by Country (2018-2023) & (MT)
Table 129. South America Escitalopram Oxalate API Sales Quantity by Country (2024-2029) & (MT)
Table 130. South America Escitalopram Oxalate API Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Escitalopram Oxalate API Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Escitalopram Oxalate API Sales Quantity by Type (2018-2023) & (MT)
Table 133. Middle East & Africa Escitalopram Oxalate API Sales Quantity by Type (2024-2029) & (MT)
Table 134. Middle East & Africa Escitalopram Oxalate API Sales Quantity by Application (2018-2023) & (MT)
Table 135. Middle East & Africa Escitalopram Oxalate API Sales Quantity by Application (2024-2029) & (MT)
Table 136. Middle East & Africa Escitalopram Oxalate API Sales Quantity by Region (2018-2023) & (MT)
Table 137. Middle East & Africa Escitalopram Oxalate API Sales Quantity by Region (2024-2029) & (MT)
Table 138. Middle East & Africa Escitalopram Oxalate API Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Escitalopram Oxalate API Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Escitalopram Oxalate API Raw Material
Table 141. Key Manufacturers of Escitalopram Oxalate API Raw Materials
Table 142. Escitalopram Oxalate API Typical Distributors
Table 143. Escitalopram Oxalate API Typical Customers
List of Figures
Figure 1. Escitalopram Oxalate API Picture
Figure 2. Global Escitalopram Oxalate API Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Escitalopram Oxalate API Consumption Value Market Share by Type in 2022
Figure 4. Both USDMF and COS/E-DM Examples
Figure 5. Only USDMF or COS/E-DM Examples
Figure 6. Global Escitalopram Oxalate API Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Escitalopram Oxalate API Consumption Value Market Share by Application in 2022
Figure 8. Depression Drug Examples
Figure 9. Anxiety Drug Examples
Figure 10. Global Escitalopram Oxalate API Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Escitalopram Oxalate API Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Escitalopram Oxalate API Sales Quantity (2018-2029) & (MT)
Figure 13. Global Escitalopram Oxalate API Average Price (2018-2029) & (US$/Kg)
Figure 14. Global Escitalopram Oxalate API Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Escitalopram Oxalate API Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Escitalopram Oxalate API by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Escitalopram Oxalate API Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Escitalopram Oxalate API Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Escitalopram Oxalate API Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Escitalopram Oxalate API Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Escitalopram Oxalate API Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Escitalopram Oxalate API Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Escitalopram Oxalate API Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Escitalopram Oxalate API Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Escitalopram Oxalate API Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Escitalopram Oxalate API Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Escitalopram Oxalate API Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Escitalopram Oxalate API Average Price by Type (2018-2029) & (US$/Kg)
Figure 29. Global Escitalopram Oxalate API Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Escitalopram Oxalate API Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Escitalopram Oxalate API Average Price by Application (2018-2029) & (US$/Kg)
Figure 32. North America Escitalopram Oxalate API Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Escitalopram Oxalate API Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Escitalopram Oxalate API Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Escitalopram Oxalate API Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Escitalopram Oxalate API Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Escitalopram Oxalate API Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Escitalopram Oxalate API Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Escitalopram Oxalate API Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Escitalopram Oxalate API Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Escitalopram Oxalate API Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Escitalopram Oxalate API Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Escitalopram Oxalate API Consumption Value Market Share by Region (2018-2029)
Figure 52. China Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Escitalopram Oxalate API Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Escitalopram Oxalate API Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Escitalopram Oxalate API Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Escitalopram Oxalate API Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Escitalopram Oxalate API Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Escitalopram Oxalate API Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Escitalopram Oxalate API Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Escitalopram Oxalate API Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Escitalopram Oxalate API Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Escitalopram Oxalate API Market Drivers
Figure 73. Escitalopram Oxalate API Market Restraints
Figure 74. Escitalopram Oxalate API Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Escitalopram Oxalate API in 2022
Figure 77. Manufacturing Process Analysis of Escitalopram Oxalate API
Figure 78. Escitalopram Oxalate API Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source